Although the study was not powered for efficacy outcomes, there was a lower proportion of thrombotic events in the rivaroxaban group relative to the ASA group, although this did not reach statistical significance.
← all excerpts
Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE Study.
1
—
—